Discovery of a Series of Hydroxamic Acid-Based Microtubule Destabilizing Agents with Potent Antitumor Activity (vol 64, pg 15379, 2021)

被引:0
|
作者
Yang, Linyu
Zhang, Wanhua
Qiu, Qiang
Su, Zhengying
Tang, Minghai
Bai, Peng
Si, Wenting
Zhu, Zejiang
Liu, Yan
Yang, Jianhong
Kuang, Shuang
Liu, Jiang
Yan, Wei
Shi, Mingsong
Ye, Haoyu
Yang, Zhuang
Chen, Lijuan
机构
关键词
D O I
10.1021/acs.jmedchem.2c01176
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
引用
收藏
页码:11890 / 11890
页数:1
相关论文
共 28 条
  • [1] Discovery of a Series of Hydroxamic Acid-Based Microtubule Destabilizing Agents with Potent Antitumor Activity
    Yang, Linyu
    Zhang, Wanhua
    Qiu, Qiang
    Su, Zhengying
    Tang, Minghai
    Bai, Peng
    Si, Wenting
    Zhu, Zejiang
    Liu, Yan
    Yang, Jianhong
    Kuang, Shuang
    Liu, Jiang
    Yan, Wei
    Shi, Mingsong
    Ye, Haoyu
    Yang, Zhuang
    Chen, Lijuan
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (20) : 15379 - 15401
  • [2] Discovery of Novel Quinoline-Chalcone Derivatives as Potent Antitumor Agents with Microtubule Polymerization Inhibitory Activity
    Li, Wenlong
    Xu, Feijie
    Shuai, Wen
    Sun, Honghao
    Yao, Hong
    Ma, Cong
    Xu, Shengtao
    Yao, Hequan
    Zhu, Zheying
    Yang, Dong-Hua
    Chen, Zhe-Sheng
    Xu, Jinyi
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (02) : 993 - 1013
  • [3] Novel carbazole sulfonamide microtubule-destabilizing agents exert potent antitumor activity against esophageal squamous cell carcinoma
    Niu, Fangfei
    Liu, Yonghua
    Jing, Zongpan
    Han, Gaijing
    Sun, Lianqi
    Yan, Lu
    Zhou, Lanping
    Wu, Yanbin
    Xu, Yang
    Hu, Laixing
    Zhao, Xiaohang
    CANCER LETTERS, 2018, 420 : 60 - 71
  • [4] Discovery of novel 2-(trifluoromethyl)quinolin-4-amine derivatives as potent antitumor agents with microtubule polymerization inhibitory activity
    Liu, Kun
    Mo, Min
    Yu, Gang
    Yu, Jia
    Song, Shan-min
    Cheng, Sha
    Li, Hui-min
    Meng, Xue-ling
    Zeng, Xiao-ping
    Xu, Guang-can
    Luo, Heng
    Xu, Bi-xue
    BIOORGANIC CHEMISTRY, 2023, 139
  • [5] Discovery of a Tetrahydroisoquinoline-Based Hydroxamic Acid Derivative (ZYJ-34c) as Histone Deacetylase Inhibitor with Potent Oral Antitumor Activities
    Zhang, Yingjie
    Fang, Hao
    Feng, Jinhong
    Jia, Yuping
    Wang, Xuejian
    Xu, Wenfang
    JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (15) : 5532 - 5539
  • [6] SKLB-14b, a novel oral microtubule-destabilizing agent based on hydroxamic acid with potent anti-tumor and anti-multidrug resistance activities
    Zhang, Wanhua
    Yang, Linyu
    Si, Wenting
    Tang, Minghai
    Bai, Peng
    Zhu, Zejiang
    Kuang, Shuang
    Liu, Jiang
    Shi, Mingsong
    Huang, Jinxing
    Chen, Xuanming
    Li, Dan
    Wen, Yi
    Yang, Zhuang
    Xiao, Kai
    Chen, Lijuan
    BIOORGANIC CHEMISTRY, 2022, 128
  • [7] Exploration of Structure-Activity Relationship Using Integrated Structure and Ligand Based Approach: Hydroxamic Acid-Based HDAC Inhibitors and Cytotoxic Agents
    Shirbhate, Ekta
    Pandey, Jaiprakash
    Patel, Vijay Kumar
    Veerasamy, Ravichandran
    Rajak, Harish
    TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 20 (04) : 270 - 284
  • [8] Hydroxamic Acid-Based Histone Deacetylase (HDAC) Inhibitors Can Mediate Neuroprotection Independent of HDAC Inhibition (vol 34, pg 14328, 2014)
    Sleiman, Sama F.
    Olson, David E.
    Bourassa, Megan W.
    Karuppagounder, Saravanan S.
    Zhang, Yan-Ling
    Gale, Jennifer
    Wagner, Florence F.
    Basso, Manuela
    Coppola, Giovanni
    Pinto, John T.
    Holson, Edward B.
    Ratan, Rajiv R.
    JOURNAL OF NEUROSCIENCE, 2015, 35 (01): : 438 - 438
  • [9] Discovery of Chromane-6-Sulfonamide Derivative as a Potent, Selective, and Orally Available Novel Retinoic Acid Receptor-Related Orphan Receptor γt Inverse Agonist (vol 64, pg 16106, 2021)
    Chen, Lei
    Su, Mei
    Wang, Wei
    Wang, Chun-Gu
    Assani, Israa
    Wang, Mu-Xuan
    Zhao, Shi-Feng
    Lv, Shen-Min
    Wang, Jia-Wei
    Sun, Bo
    Li, Yan
    Jin, Qiu
    Liao, Zhi-Xin
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (24) : 18235 - 18235
  • [10] Discovery of Chromane-6-Sulfonamide Derivative as a Potent, Selective, and Orally Available Novel Retinoic Acid Receptor-Related Orphan Receptor γt Inverse Agonist (vol 64, pg 16106, 2021)
    Chen, Lei
    Su, Mei
    Wang, Wei
    Wang, Chun-Gu
    Assani, Israa
    Wang, Mu-Xuan
    Zhao, Shi-Feng
    Lv, Shen-Min
    Wang, Jia-Wei
    Sun, Bo
    Li, Yan
    Jin, Qiu
    Liao, Zhi-Xin
    JOURNAL OF MEDICINAL CHEMISTRY, 2021,